2.50
Hdl Handle:
http://hdl.handle.net/10755/160625
Type:
Presentation
Title:
Treatment of Stage I and Stage II Pressure Ulcers in Critically Ill Patients
Abstract:
Treatment of Stage I and Stage II Pressure Ulcers in Critically Ill Patients
Conference Sponsor:Midwest Nursing Research Society
Conference Year:2000
Author:Coon, Jane, DNS/DNSc/DSN
P.I. Institution Name:University of Michigan School of Nursing
Title:Assistant Professor
Contact Address:1406 Warrington Dr., Ann Arbor, MI, 48103, USA
Contact Telephone:313.647.0128
The purpose of this ongoing study is to test whether the addition of a non-alcohol polymer skin protectant to treatment protocols will enhance ulcer healing in critically ill patients with early pressure ulcers. Patients who have Stage I or II heel or sacral pressure ulcers are randomly assigned to a treatment protocol with or without the skin protectant. Patients are followed until the ulcer is healed, hospital discharge, or 28 days. Change in wound size is determined by tracings measured using Image PC. The rate of linear healing is calculated using the formula recommended by Gilman. Fifty-three patients have been studied for an average of 16.4 days. There are no statistically significant differences between the two groups with regard to demographics, severity of illness, or pre-treatment ulcer size, location or stage. After controlling for length of follow-up, the linear healing rate for ulcers treated with the skin protectant appears to be significantly faster than for ulcers treated without the skin protectant (p=0.014). Addition of a non-alcohol polymer skin protectant to treatment protocols for early pressure ulcers should enhance wound healing in critically ill patients. 3M No Sting Barrier Film Scion Corporation Research funded by 3M Healthcare
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Midwest Nursing Research Society

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleTreatment of Stage I and Stage II Pressure Ulcers in Critically Ill Patientsen_GB
dc.identifier.urihttp://hdl.handle.net/10755/160625-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Treatment of Stage I and Stage II Pressure Ulcers in Critically Ill Patients</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Midwest Nursing Research Society</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2000</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Coon, Jane, DNS/DNSc/DSN</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">University of Michigan School of Nursing</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Assistant Professor</td></tr><tr class="item-address"><td class="label">Contact Address:</td><td class="value">1406 Warrington Dr., Ann Arbor, MI, 48103, USA</td></tr><tr class="item-phone"><td class="label">Contact Telephone:</td><td class="value">313.647.0128</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">jwcoon@umich.edu</td></tr><tr><td colspan="2" class="item-abstract">The purpose of this ongoing study is to test whether the addition of a non-alcohol polymer skin protectant to treatment protocols will enhance ulcer healing in critically ill patients with early pressure ulcers. Patients who have Stage I or II heel or sacral pressure ulcers are randomly assigned to a treatment protocol with or without the skin protectant. Patients are followed until the ulcer is healed, hospital discharge, or 28 days. Change in wound size is determined by tracings measured using Image PC. The rate of linear healing is calculated using the formula recommended by Gilman. Fifty-three patients have been studied for an average of 16.4 days. There are no statistically significant differences between the two groups with regard to demographics, severity of illness, or pre-treatment ulcer size, location or stage. After controlling for length of follow-up, the linear healing rate for ulcers treated with the skin protectant appears to be significantly faster than for ulcers treated without the skin protectant (p=0.014). Addition of a non-alcohol polymer skin protectant to treatment protocols for early pressure ulcers should enhance wound healing in critically ill patients. 3M No Sting Barrier Film Scion Corporation Research funded by 3M Healthcare</td></tr></table>en_GB
dc.date.available2011-10-26T23:07:24Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T23:07:24Z-
dc.description.sponsorshipMidwest Nursing Research Societyen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.